Litigation Details for Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. - LEAD CASE (D. Mass. 2015)

Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. - LEAD CASE (D. Mass. 2015)

Docket		Date Filed	2015-08-06
Court	District Court, D. Massachusetts	Date Terminated
Cause	35:145 Patent Infringement	Assigned To	F. Dennis Saylor IV
Jury Demand	Defendant	Referred To
Patents	7,674,799; 7,674,800; 7,683,072; 8,114,383; 9,073,933; 9,522,919
Link to Docket	External link to docket

Details for Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. - LEAD CASE (D. Mass. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-08-06	1	Complaint	three API patents, U.S. Patent Nos. 7,674,799, 7,674,800, and 7,683,072 (“the Improved API patents”), are…claims 3 and 19 of U.S. Patent No. 7,674,799; claims 30-34 and 76-79 of U.S. Patent No. 7,674,800; claims…infringed U.S. Patent Nos. 7,674,799, 7,674,800, and 7,683,072 (“the Improved API patents”), and that the…right, title and interest in United States Patent No. 7,674,799 entitled “OXYCODONE HYDROCHLORIDE… infringement of U.S. Patent No. 8,652,497 (“the ‘497 Abuse-deterrence patent”), which relates to an	External link to document
2017-06-01	139		Invalidity And Non-Infringement Of U.S. Patent Nos. 9,073,933, 8,652,497, And 9,155,717, Defendant Collegium… 6 August 2015 1:15-cv-13099-FDS Patent Defendant District Court, D.	External link to document
2017-11-21	150		the 8α-removing, low-ABUK patent: U.S. Patent No. 9,073,933 (“the ’933 Patent”). 1. …oxycodone: U.S. Patent Nos. 8,652,497 (“the ’497 patent”) and 9,155,717 (“the ’717 Patent”). FAC, Exs. …low-toxicity patent.” (Id. ¶ 3, 12). Purdue Pharmaceuticals L.P. also owns the low-toxicity patent and manufactures… B. Patents at Issue Purdue Pharma L.P., is the named assignee on two patents related to… The ’497 Patent The ’497 patent is entitled “Pharmaceutical Formulation Containing Irritant	External link to document
2018-02-26	165		counts of infringement of U.S. Patent No. 9,522,919, the only patent at issue in member case 17-cv-10690… 6 August 2015 1:15-cv-13099-FDS Patent Defendant District Court, D.	External link to document
2018-09-28	193	Memorandum & Order	infringed U.S. Patent Nos. 7,674,799 (“the ’799 patent”), 7,647,800 (“the ’800 patent”), and 7,683,072…are U.S. Patent Nos. 9,073,933 (“the ’933 patent”), 8,652,497 (“the ’497 patent”), and 9,155,717 (“the…13, 2015. (’717 Patent). The ’717 patent shares a specification with the ’497 patent. C. …three related patents pursuant to 35 U.S.C. §§ 271(a), (b), (c), and (e)(2)(A). The patents at issue are…related patents owned by Purdue are invalid. Second, Collegium asserts that even if the ’933 patent is valid	External link to document
2015-11-09	27		invalidity of U.S. Patent Nos. 7,674,799 (the “’799 patent”), 7,674,800 (the “’800 patent”), and 7,683,072…enter final judgment of invalidity of U.S. Patent Nos. 7,674,799, 7,674,800, and 7,683,072. 86245129.1…three listed patents (that decision refers to the listed patents as the Low-ABUK patents). See Purdue…7,683,072 (the “’072 patent”) (collectively, “the listed patents”) based on collateral estoppel. Plaintiffs…plaintiffs, the same patents, and the same issues of invalidity with respect to the listed patents.	External link to document
2015-11-23	31		7,674,799, 7,674,800, and 7,683,072 (“the Listed Patents”), 1 which are directed to oxycodone API with…numerous patented inventions, including the patents asserted against Collegium: (i) U.S. Patents Nos. 7,674,799…issued U.S. Patent No. 9,073,933 (“the ’933 patent”), from the same family as the Listed Patents (and also…Orange Book patents. See 21 U.S.C. § 355(b)(2)(A). 2 The Listed Patents and the ‘497 patent are at … genotoxic impurity; (ii) U.S. Patent No. 8,652,497 (“the ’497 patent”), which discloses and claims deterring	External link to document